Helen Ligard, vice president of corporate strategy for Parexel, and Jim Reilly, vice president for Vault R&D at Veeva Systems, discuss how Parexel and Veeva are bringing the industry one step closer to faster, more efficient clinical trials.
Helen Ligard, vice president of corporate strategy for Parexel, and Jim Reilly, vice president for Vault R&D at Veeva Systems, discuss how Parexel and Veeva are bringing the industry one step closer to faster, more efficient clinical trials.